Fig. 6
From: Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma
Time-dependent ROC analysis of combined the risk score and clinical characteristics. a Time-dependent ROC analysis of the sensitivity and specificity of combined the risk score and N stage. b Time-dependent ROC analysis of the sensitivity and specificity of combined the risk score and lymphatic invasion. c Time-dependent ROC analysis of the sensitivity and specificity of combined the risk score, N stage and lymphatic invasion